retatrutide update This New Can Change Everything π (Shocking Results) Big News: GLP-1 Medicine update
Description
The American Association for the Study of Liver Diseases (AASLD) acknowledges the potential role of GLP-1 receptor agonists in managing MASLD, particularly in patients with concurrent type 2 diabetes or obesity
The Convenience Paradox We assume "pills are easier than shots." But the Wegovy pill requires restructuring your entire morning routine
In contrast, tirzepatide is already approved for both obesity (Zepbound) and type 2 diabetes (Mounjaro)
GLP-1 is an incretin hormone produced in the gut that enhances insulin secretion in response to food intake while suppressing glucagon, slowing gastric emptying, and reducing appetite ( [1] ) ( [2] )
Trainers are the missing piece
